Glucose metabolism after renal transplantation

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2763-2771

  Hecking, Manfred ^a   Kainz, Alexander ^a   Werzowa, Johannes ^a   Haidinger, Michael ^a   Döller, Dominik ^a   Tura, Andrea ^b   Karaboyas, Angelo ^c   Hörl, Walter H ^a   Wolzt, Michael ^a   Sharif, Adnan ^d   Roden, Michael ^e   Moro, Ermanno ^f   Pacini, Giovanni ^b   Port, Friedrich K ^c   Säemann, Marcus D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CNR   (Italy)

^c ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^f Venice Regional General Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CYCLOSPORIN A; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; TACROLIMUS;

ADULT; AGE; ARTICLE; BODY MASS; CELL FUNCTION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW ONSET DIABETES AFTER TRANSPLANTATION; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84890997514     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2441     Document Type: Article

References (41)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients. (SRTR) 2010 Annual Data Report, 2011. Available from http://www.srtr.org/annual-reports/2010/ pdf/2010-SRTR-ADR.pdf. Accessed 26 March 2012
2. U.S. Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, 2012. Available from http://www.usrds.org/adr.aspx. Accessed 18 January 2013
3. Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed newonset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006;69: 588-595
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35(Suppl. 1):S64- S71
5. Hjelmesaeth J, Hagen M, Hartmann A, Midtvedt K, Egeland T, Jenssen T. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant 2002;16: 389-396
6. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 2003;18: 2154-2159
7. Nam JH, Mun JI, Kim SI, et al. beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71: 1417-1423
8. Midtvedt K, Hartmann A, Hjelmesaeth J, Lund K, Bjerkely BL. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients. Nephrol Dial Transplant 1998;13: 427-431
9. Shimizu M, Iino Y, Terashi A. [Improvement of insulin sensitivity after renal transplantation measured by a glucose clamp technique] [article in Japanese]. Nippon Ika Daigaku Zasshi 1998;65: 50-54
10. Zelle DM, Corpeleijn E, Deinum J, et al. Pancreaticb-cell dysfunction and risk of newonset diabetes after kidney transplantation. Diabetes Care 2013;36: 1926-1932
11. Hornum M, Jørgensen KA, Hansen JM, et al. New-onset diabetes mellitus after kidney transplantation in Denmark. Clin J Am Soc Nephrol 2010;5: 709-716
12. Heit JJ, Apelqvist AA, Gu X, et al. Calcineurin/ NFAT signalling regulates pancreatic beta-cell growth and function. Nature 2006;443: 345-349
13. Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab 2007;292: E654-E667
14. van Raalte DH, Nofrate V, Bunck MC, et al. Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. Eur J Endocrinol 2010;162: 729-735
15. Davidson J, Wilkinson A, Dantal J, et al.; International Expert Panel. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003;75(Suppl.): SS3-SS24
16. Hecking M, Haidinger M, Döller D, et al. Early basal insulin therapy decreases newonset diabetes after renal transplantation. J Am Soc Nephrol 2012;23: 739-749
17. Kautzky-Willer A, Brazzale AR, Moro E, et al. Influence of increasing BMI on insulin sensitivity and secretion in normotolerant men and women of a wide age span. Obesity (Silver Spring) 2012;20: 1966-1973
18. Goldstein DE, Little RR, Wiedmeyer HM, England JD, McKenzie EM. Glycated hemoglobin: methodologies and clinical applications. Clin Chem 1986;32(Suppl.): B64-B70
19. Vezzosi D, Bennet A, Fauvel J, Caron P. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol 2007;157: 75-83
20. Tura A, Kautzky-Willer A, Pacini G. Insulinogenic indices from insulin and Cpeptide: comparison of beta-cell function fromOGTT and IVGTT. Diabetes Res Clin Pract 2006;72: 298-301
21. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24: 539-548
22. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85: 2402-2410
23. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and betacell function. Best Pract Res Clin Endocrinol Metab 2003;17: 305-322
24. Anderwald C, Pfeiler G, Nowotny P, et al. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring. Eur J Clin Invest 2008;38: 227-237
25. Nosadini R, del Prato S, Tiengo A, et al. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes 1982;31: 346-355
26. Weir GC, Bonner-Weir S. A dominant role for glucose in beta cell compensation of insulin resistance. J Clin Invest 2007;117: 81-83
27. Sharif A, Moore RH, Baboolal K. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon. Transplantation 2006;82: 1667-1672
28. Delgado P, Diaz JM, Silva I, et al. Unmasking glucose metabolism alterations in stable renal transplant recipients: a multicenter study.Clin JAmSoc Nephrol 2008; 3: 808-813
29. Valderhaug TG, Jenssen T, Hartmann A, et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 2009;88: 429-434
30. Luan FL, Stuckey LJ, Ojo AO. Abnormal glucose metabolism and metabolic syndrome in non-diabetic kidney transplant recipients early after transplantation. Transplantation 2010;89: 1034-1039
31. Vincenti F, Friman S, Scheuermann E, et al.; DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007;7: 1506-1514
32. [corrected in Am J Transplant 2008;8:908]
33. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002;62: 1440-1446
34. Ekstrand AV, Eriksson JG, Grönhagen- Riska C, Ahonen PJ, Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 1992;53: 563-569
35. Øzbay LA, Møller N, Juhl C, et al. Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers. Br J Clin Pharmacol 2012;73: 536-545
36. Kowall B, Rathmann W, Heier M, et al. Categories of glucose tolerance and continuous glycemic measures and mortality. Eur J Epidemiol 2011;26: 637-645
37. Kahl S, Livingstone N, Nowotny B, et al. Validation of indices predicting hepatic steatosis by 1H-magnetic resonance spectroscopy and their correlation with glucose tolerance. Diabetologia 2012;55 (Suppl. 1):S135
38. Roden M, Mariz S, Brazzale AR, Pacini G. Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes. J Intern Med 2009;265: 476-487
39. Staten MA, Stern MP, Miller WG, Steffes MW, Campbell SE; Insulin Standardization Workgroup. Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care. Diabetes Care 2010;33: 205-206
40. Nyalakonda K, Sharma T, Ismail-Beigi F. Preservation of beta-cell function in type 2 diabetes. Endocr Pract 2010;16: 1038-1055
41. Sharif A. Should metformin be our antiglycemic agent of choice post-transplantation? Am J Transplant 2011;11: 1376-1381